Kymera Therapeutics, Inc. - KYMR Income before deduction of interest, taxes and amortization

Graphic logo of kymeratx.com (KYMR)

Kymera Therapeutics (KYMR) is accelerating the development of breakthrough targeted protein degradation methods to combat oncology. The operating profit (EBIT) trend visualizes this dynamics, while the 0.00 indicator confirms the current level. The innovative platform enables the elimination of previously inaccessible targets, while strategic management minimizes financial risks through transparent governance and large-scale partnerships.

Kymera Therapeutics Inc - KYMR Operating profit EBITDA (period 11/23/2025 - 11/15/2026)

Kymera Therapeutics, Inc. (KYMR) - metric breakdowns and financial figures

- market value and analyst target forecast:
Summary company analytics:Kymera Therapeutics
Brand item of Kymera

By leveraging an asset-light model and outsourcing production to contract partners, Kymera Therapeutics (KYMR) minimizes capital expenditures to focus on R&D. By analyzing quarterly EBITDA, investors assess the net cash flow from operating activities excluding depreciation and taxes, which determines the company's liquidity resilience relative to the cost of debt and confirms the asset's reliability amid the Fed's tight monetary policy.

Competitor analysis for Kymera Therapeutics

Genmab (GMAB) - Profit before interest, taxes and amortization|EXEL: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization NUVL (Nuvalent Corp)|IDYA (IDEAYA Biosciences, Inc.) - Operating profit before deduction of amortization|ELVN: Company profit before taxes, interest and amortization|ORIC (ORIC Corp) - Operating profit EBITDA|Operating profit EBITDA relaytx.com|Profit before payment of interest, taxes and amortization Nurix Therapeutics, Inc. (NRIX)|TYRA (Tyra Biosciences) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA VSTM (Verastem Oncology)|Operating profit before depreciation charges Monte Rosa Tx|Cullinan Oncology - Operating profit EBITDA|Profit before interest, taxes and amortization Immuneering|CCCC (C4 Therapeutics, Inc.) - Operating profit before deduction of amortization|BDTX: Company profit before taxes, interest and amortization|RPTX (reparerx.com) - Operating profit EBITDA|Profit before interest, taxes and amortization PMV Pharma PMVP|Operating profit EBITDA KPTI|Propanc Biopharma, Inc. - Operating profit before amortization|Bio Green Med Solution - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AADI|ALRN: Operating profit before deduction of amortization|blueprintmedicines.com - Company profit before taxes, interest and amortization|GLYC: Operating profit EBITDA|SpringWorks Therapeutics - Income before deduction of interest, taxes and amortization